PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
8.34%
Net income growth at 75-90% of META's 10.17%. Bill Ackman would call for strategic or operational tweaks to match competitor’s earnings growth.
16.07%
D&A growth well above META's 11.33%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
87.46%
Some yoy growth while META is negative at -17.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
14.46%
SBC growth well above META's 16.57%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-103.71%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
19.56%
AR growth while META is negative at -147.72%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-273.51%
Negative yoy inventory while META is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
7.61%
Lower AP growth vs. META's 144.49%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
26.43%
Lower 'other working capital' growth vs. META's 93.48%. David Dodd would see fewer unexpected short-term demands on cash.
-195.16%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
5.09%
Operating cash flow growth at 75-90% of META's 6.39%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
-24.09%
Both yoy lines negative, with META at -27.80%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-3640.01%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
33.72%
Some yoy expansion while META is negative at -95.19%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
29.92%
Below 50% of META's 198.35%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
No Data
No Data available this quarter, please select a different quarter.
-60.72%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.